NOVAVAX 11.16USD + 7.83%
NOVAVAX is going to begin a phase 1 clinical study of its experimental COVID 19 vaccine anytime from now till May and it is currently evaluating several nanoparticle vaccine candidates to select the most promising one to go to the next level of advanced clinical testing.
If the results of the Nanoflu are positive Novavax will quickly go to the U.S regulatory approval of the vaccine and investors are positive when it comes to Novavx because it had positive results in another clinical test that is why it keeps going high.